Hypertension remains the leading cause of global mortality, with elevated systolic blood pressure (BP) leading to 10.8 million deaths each year. Despite this, only around 50% of individuals with hypertension are aware of their condition. Alongside low awareness rates, lack of patient adherence to medication and therapeutic inertia have been identified as factors contributing to the lack of hypertension control worldwide. This report summarizes presentations from the “one of a kind” Servier-sponsored symposium, Improving the Management of Hypertension: Acting on Key Factors, which was conducted as part of the European Society of Hypertension (ESH)-International Society of Hypertension (ISH) 2021 ON-AIR meeting. The symposium focused on how low awareness, therapeutic inertia, and nonadherence can be addressed by combining the experience of a patient with the expertise of physicians. May Measurement Month, the ongoing global BP measurement program, is raising awareness of hypertension in over 90 countries, and the 2018 European Society of Cardiology/ESH guidelines and the 2020 ISH guidelines now include recommendations that specifically address low adherence and therapeutic inertia, including involving patients in a shared decision-making process and the use of single-pill combination therapy. Understanding the role of emotion in decision making and addressing the different psychological states and attitudes in the patient’s “cycle of change” are key to effective shared decision making and improving adherence.

高血压仍然是全球死亡的主要原因，收缩压 (BP) 升高每年导致 1080 万人死亡。尽管如此，只有大约 50% 的高血压患者知道自己的病情。除了知晓率低之外，患者对药物缺乏依从性和治疗惰性已被确定为导致全球高血压控制不足的因素。本报告总结了施维雅赞助的“独一无二”研讨会的发言，“改善高血压管理：针对关键因素采取行动”，这是作为欧洲高血压学会 (ESH)-国际高血压学会 (ISH) 2021 ON-AIR 会议的一部分进行的。研讨会的重点是如何通过将患者的经验与医生的专业知识相结合来解决低意识、治疗惰性和不依从性问题。正在进行的全球血压测量计划五月测量月正在提高 90 多个国家对高血压的认识，2018 年欧洲心脏病学会/ESH 指南和 2020 年 ISH 指南现在包括专门解决低依从性和治疗惰性的建议，包括涉及患者在共享决策过程中使用单药联合治疗。